G 341 (Oxybutynin chloride extended release 5 mg)

Pill imprint G 341 has been identified as Oxybutynin chloride extended release 5 mg.

Oxybutynin is used in the treatment of overactive bladder; urinary incontinence; hyperhidrosis; dysuria; prostatitis and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for G 341

Oxybutynin chloride extended release 5 mg G 341
Oxybutynin chloride extended release 5 mg G 341
Oxybutynin chloride extended release 5 mg G 341
Oxybutynin chloride extended release
Imprint:
G 341
Strength:
5 mg
Color:
Purple
Size:
7.00 mm
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
Urinary antispasmodics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-5206
Inactive Ingredients:
hypromelloses
lactose monohydrate
methacrylic acid
microcrystalline cellulose
magnesium silicate
triethyl citrate
FD&C Blue No. 2
FD&C Red No. 40

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)